logo
Select company
Select metric
-78.08%Return on Equity
VS
Market
14
Sector
37
Industry
47
History
25
$ 1.65Close
$ 1.06 - $ 4.46 52-Week Range
Ticker Information

Ticker

MGNX

Company Name

MACROGENICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MACROGENICS INC - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MGNX - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ 46.62M$ -36.4M-78.08%
3/31/2025$ 79.12M$ -55.81M-70.54%
12/31/2024$ 116.06M$ -66.97M-57.7%
9/30/2024$ 120.07M$ -97.62M-81.3%
6/30/2024$ 57.82M$ -136.37M-235.86%
3/31/2024$ 106.15M$ -23.24M-21.89%
12/31/2023$ 152.61M$ -9.06M-5.94%
9/30/2023$ 193.98M$ 49.82M25.68%
6/30/2023$ 171.54M$ 7.45M4.34%
3/31/2023$ 109.27M$ -91.32M-83.58%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MACROGENICS INC's latest trailing twelve months (TTM) ROE stands at -54.2%.
  • Over the past 5 years, MACROGENICS INC's average ROE has been -71.58%.
  • The median ROE for MACROGENICS INC during this period was -64.12%
  • MACROGENICS INC reached its highest ROE over the past 5 years at 25.68%.
  • The lowest ROE recorded by MACROGENICS INC in the same timeframe -235.86%

MACROGENICS INC's ROE vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROE Benchmarks
CompanyROE
CHRS : COHERUS ONCOLOGY INC 150.01%IGMS : IGM BIOSCIENCES INC -52.89%ATRA : ATARA BIOTHERAPEUTICS INC -STRO : SUTRO BIOPHARMA INC -AGEN : AGENUS INC -CELU : CELULARITY INC -CSBR : CHAMPIONS ONCOLOGY INC 84.15%IVVD : INVIVYD INC -257.38%PLX : PROTALIX BIOTHERAPEUTICS INC 12.57%BDTX : BLACK DIAMOND THERAPEUTICS INC 10.89%

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for MACROGENICS INC is calculated as follows: Net Inc. Cmn. [ $ -158.05M ] / Equity [ $ 291.58M ]
(=) ROE [ -54.2% ]

MGNX - Return on Equity, Last 5 years

-235.86%

Minimum

Jun 30, 2024

25.68%

Maximum

Sep 30, 2023

-71.58%

Average

-64.12%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.14K
min-66.79%
max73.25%
average1.51%
median6.45%
std22.67%